Administration of a lysozyme hydrolysate with alcalase did not modify body weight, nor improved the metabolic parameters of obese diabetic Zucker rats, but it exerted beneficial effects on renal damage and endothelial dysfunction, at least partially through a decreasing effect on oxidative stress [11]. The gene discussed is LYZ; the disease is endothelial dysfunction.